Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline
- PMID: 14578610
- DOI: 10.1253/circj.67.810
Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline
Abstract
Atrial electrograms were recorded from the high right atrium, coronary sinus, and right lateral wall in 15 patients with induced atrial fibrillation (AF). Intravenous cibenzoline terminated AF in 8 patients (T group), but not in 7 patients (non-T group). The cycle length of the AF (AFCL) obtained by the autocorrelation function was measured every 5 s during the 30 s prior to the cibenzoline administration, and just before the termination of AF or at the end of the cibenzoline infusion in the non-T group. The mean AFCL, and spatial and temporal dispersion of the AFCL were then compared between the 2 groups (dispersion = standard deviation x 100 /mean AFCL). Cibenzoline significantly increased the mean AFCL and decreased the spatial dispersion in both groups. No significant difference in either the mean AFCL or temporal dispersion before or after cibenzoline was observed between the 2 groups. In addition, no significant difference in the spatial dispersion before the cibenzoline was observed, but the spatial dispersion after the cibenzoline was significantly smaller in the T group than in the non-T group. The mean AFCL, and the spatial and temporal dispersion before the cibenzoline did not predict the termination of AF. The decrease in the spatial dispersion may be the most important mechanism by which intravenous cibenzoline terminates AF.
Similar articles
-
Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.J Cardiovasc Electrophysiol. 2004 May;15(5):572-80. doi: 10.1046/j.1540-8167.2004.03402.x. J Cardiovasc Electrophysiol. 2004. PMID: 15149428
-
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.Circulation. 2000 Jul 11;102(2):260-7. doi: 10.1161/01.cir.102.2.260. Circulation. 2000. PMID: 10889140
-
Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.J Cardiovasc Electrophysiol. 2006 Jun;17(6):648-54. doi: 10.1111/j.1540-8167.2006.00407.x. J Cardiovasc Electrophysiol. 2006. PMID: 16836716
-
[Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].Ann Cardiol Angeiol (Paris). 1995 Jan;44(1):49-55. Ann Cardiol Angeiol (Paris). 1995. PMID: 7702357 Review. French.
-
Electrophysiological properties of the human atrium in atrial fibrillation.Cardiovasc Res. 2002 May;54(2):302-14. doi: 10.1016/s0008-6363(02)00262-6. Cardiovasc Res. 2002. PMID: 12062336 Review.
Cited by
-
Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?J Cardiovasc Pharmacol. 2020 Nov;76(5):492-505. doi: 10.1097/FJC.0000000000000892. J Cardiovasc Pharmacol. 2020. PMID: 33165131 Free PMC article. Review.
-
"Pharmacological" analysis of atrial fibrillation maintenance mechanism: reentry, wavelets, or focal?Front Cardiovasc Med. 2025 Jan 24;12:1447542. doi: 10.3389/fcvm.2025.1447542. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 39925977 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical